EQS-News: BioCorRx Inc
/ Key word(s): Financial
BioCorRx Reports 3,985% Revenue Growth to $313K in the First Half of 2025 Driven by LUCEMYRA(R) (lofexidine) Sales 14.08.2025 / 20:30 CET/CEST
The issuer is solely responsible for the content of…Read More
You might also be interested in reading Bitcoin price trades near key $31.7K pivot point — Can BTC bulls keep up the volume?.